2024
The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions
Alameddine D, Damara F, Pinto Rodriguez P, Huttler J, Slade M, Arhuidese I, Aboian E, Ochoa Chaar C. The Use and Impact of Cilostazol on Patients Undergoing Endovascular Peripheral Interventions. Annals Of Vascular Surgery 2024, 103: 47-57. PMID: 38387798, DOI: 10.1016/j.avsg.2023.12.071.Peer-Reviewed Original ResearchImpact of cilostazolPeripheral vascular interventionsPeripheral arterial diseaseTreatment of intermittent claudicationRates of long-term mortalityPeripheral vascular interventional proceduresKaplan-Meier methodCongestive heart failureLong-term mortalityLong-term outcomesEndovascular peripheral interventionsRenal complicationsPatient demographicsBaseline characteristicsHeart failureDiabetes mellitusArtery diseaseIntermittent claudicationCilostazolPatientsVascular interventionsPeripheral interventionsClaudicationOutcomesIntervention
2015
Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care
Zarkowsky DS, Hicks CW, Arhuidese I, Canner JK, Obeid T, Qazi U, Schneider E, Abularrage CJ, Black JH, Freischlag JA, Malas MB. Quality Improvement Targets for Regional Variation in Surgical End-Stage Renal Disease Care. JAMA Surgery 2015, 150: 764-770. PMID: 26107005, DOI: 10.1001/jamasurg.2015.1126.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseUS Renal Data SystemFirst hemodialysisNephrology careAVF accessMortality hazardEnd-stage renal disease careLogistic regressionCongestive heart failureRenal replacement therapyMultivariable logistic regressionArteriovenous fistula accessQuality improvement targetsPatient comorbiditiesHeart failurePatient characteristicsRenal diseaseDisease careESRD mortalityReplacement therapyFistula accessUnivariate analysisRetrospective analysisBest practice guidelinesMAIN OUTCOME